LexaGene is developing on-site, automated and sensitive instrumentation for rapid pathogen detection for veterinary diagnostics, food safety, and other markets.
Our breakthrough technology will transform how pathogens are detected and deliver results in about an hour.
21 January 2020 – Newly-developed Tests Achieve 100% Concordance on Superbug Strains from the CDC.
Innovation in the Making
Imagine a new way of testing on site for multiple pathogens that uses customized genetic screening, doesn’t require a skilled technician,
and returns results in just one hour. See what’s new with LexaGene and how we are changing the future of pathogen detection.
Forbes feature on LexaGene
Forbes full-length feature on LexaGene and our technology describes how LexaGene could be the next big medical breakthrough.
LexaGene Company Presentation
We are commercializing the first ‘open-access’ instrument for pathogen detection, allowing users an on-site instrument to target any gene sequence of interest and return results in about an hour.
LexaGene on CBS Boston
LexaGene was featured on CBS Boston 4 WBZ during the news reporting of the EEE virus outbreak in Massachusetts and other states. Watch now!